YHD · LABORATORY ANALYTICAL INSTRUMENTS

BIO.B (BIO.B) Stock

$260.00 +0.00% YHD: BIO.B —

Valuation

MetricValue
Price$260.00
Market Cap$6.96B
P/E Ratio9.33
P/B Ratio0.93
P/S Ratio3.00
EPS (TTM)$0.00
52-Week High—
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.20%
ROA7.19%
ROCE3.64%
Gross Margin10.45%
Operating Margin10.49%
Net Margin6.52%
Debt/Equity0.20
Current Ratio5.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.9B$2.8B$2.7B$2.6B$2.6B
Operating Profit$500.0M$483.0M$338.0M$269.0M$271.0M
Net Profit$4.3B$-3.6B$-637.0M$-1.8B$760.0M
EPS$140.83$-121.79$-21.82$-65.36$27.87
Op Margin17.1%17.2%12.7%10.5%10.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.8B$13.5B$12.3B$9.4B$10.6B
Total Liabilities$4.1B$3.9B$3.6B$2.8B$3.1B
Cash$471.0M$434.0M$404.0M$488.0M$532.0M
Borrowings$223.0M$1.4B$1.4B$1.4B$1.5B

Latest News

NextEra, Dominion seek regulatory approval for proposed merger Power Technology · Jul 16, 2026 AST SpaceMobile Prices $1 Billion Convertible Senior Notes Offering MT Newswires · Jul 16, 2026 Investors Are Growing Wary of AI-Related Debt Motley Fool · Jul 16, 2026 Material Handling Integration Market to Reach USD 129.53 Billion by 2036 as Warehouse Automation and Integrated Fulfillment Systems Transform Global Supply Chains | Future Market Insights PR Newswire · Jul 16, 2026 BienRaíz Launches 240 mg Magnesium Glycinate Supplement, Expanding Its Daily Wellness Portfolio with Targeted Mineral Support GlobeNewswire · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$669.0M$194.0M$375.0M$455.0M$532.0M
Investing Cash Flow$-931.0M$-1.3B$-136.0M$-349.0M$-347.0M
Financing Cash Flow$-52.0M$-212.0M$-425.0M$-218.0M$-298.0M
Net Cash Flow$-196.0M$-37.0M$-30.0M$85.0M$40.0M
Free Cash Flow$536.0M$80.0M$218.0M$266.0M$375.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA16.72
FCF Yield4.59%
Quick Ratio3.21
Interest Coverage5.53
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BIO.B

BIO.B stock trades at $260.00 with a market capitalization of $6.96B. The stock is valued at a price-to-earnings (P/E) ratio of 9.33, price-to-book of 0.93, price-to-sales of 3.00.

On profitability, BIO.B generates a return on equity (ROE) of 10.20%, return on capital employed of 3.64%, an operating margin of 10.49%, a net profit margin of 6.52%.

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides